XML 35 R20.htm IDEA: XBRL DOCUMENT v3.22.0.1
BUSINESS OPTIMIZATION CHARGES
12 Months Ended
Dec. 31, 2021
Restructuring and Related Activities [Abstract]  
BUSINESS OPTIMIZATION CHARGES
BUSINESS OPTIMIZATION CHARGES
In recent years, we have undertaken actions to transform our cost structure and enhance operational efficiency. These efforts include restructuring the organization, optimizing the manufacturing footprint, R&D operations and supply chain network, employing disciplined cost management, and centralizing and streamlining certain support functions. From the commencement of our business optimization activities in the second half of 2015 through December 31, 2021, we have incurred cumulative pre-tax costs of approximately $1.2 billion related to these actions. These costs consisted primarily of employee termination costs, implementation costs, contract termination costs, asset impairments and accelerated depreciation. We currently expect to incur additional pre-tax cash costs of
approximately $30 million through the completion of the initiatives that are currently underway, primarily related to implementation costs. We continue to pursue cost savings initiatives and, to the extent further cost savings opportunities are identified, we may incur additional restructuring charges and costs to implement business optimization programs in future periods.
We recorded the following charges related to business optimization programs in 2021, 2020, and 2019:
years ended December 31 (in millions)202120202019
Restructuring charges$91 $111 $134 
Costs to implement business optimization programs23 23 45 
Accelerated depreciation— — 
Total business optimization charges$114 $134 $184 
For segment reporting, business optimization charges are unallocated expenses.
Costs to implement business optimization programs for the years ended December 31, 2021, 2020 and 2019, respectively, consisted primarily of external consulting and transition costs, including employee compensation and related costs. The costs were generally included within cost of sales, SG&A expense and R&D expense.
For the year ended December 31, 2019, we recognized accelerated depreciation, primarily associated with facilities to be closed. The costs were recorded within cost of sales and SG&A expense.
During the years ended December 31, 2021, 2020 and 2019, we recorded the following restructuring charges:
2021
(in millions)COGSSG&AR&DTotal
Employee termination costs$37 $35 $$73 
Contract termination and other costs— — 
Asset impairments16 — — 16 
Total restructuring charges$53 $37 $$91 
2020
(in millions)COGSSG&AR&DTotal
Employee termination costs$36 $54 $$92 
Contract termination and other costs— 
Asset impairments— 11 
Total restructuring charges$48 $61 $$111 
2019
(in millions)COGSSG&AR&DTotal
Employee termination costs$13 $37 $25 $75 
Contract termination and other costs10 — 11 
Asset impairments37 48 
Total restructuring charges$60 $40 $34 $134 
In conjunction with our business optimization initiatives, we sold property that resulted in a gain of $17 million in 2020. This benefit is reflected within other operating income, net in our consolidated statement of income for the year ended December 31, 2020.
The following table summarizes activity in the liability related to our restructuring initiatives.
(in millions)
Liability balance as of December 31, 2018$101 
Charges113 
Payments (93)
Reserve adjustments(27)
Currency translation(2)
Liability balance as of December 31, 201992 
Charges116 
Payments(86)
Reserve adjustments(16)
Currency translation
Liability balance as of December 31, 2020113 
Assumed in acquisition
Charges94 
Payments(78)
Reserve adjustments(19)
Currency translation(7)
Liability balance as of December 31, 2021$109 
Reserve adjustments primarily relate to employee termination cost reserves established in prior periods.
Substantially all of our restructuring liabilities as of December 31, 2021 relate to employee termination costs, with the remaining liabilities attributable to contract termination costs. Substantially all of the cash payments for those liabilities are expected to be disbursed by the end of 2023.